Drug class

Fibric Acid Derivatives

Fibric acid derivatives, commonly referred to as fibrates, are a class of lipid-lowering medications that include agents such as gemfibrozil and fenofibrate. Read more about Fibric Acid Derivatives

86 drugs in this class 57 manufacturers

Advertisement

Drugs in Fibric Acid Derivatives

Showing 64–72 of 86 drugs

FENOFIBRIC ACID

FIBRIC ACID DERIVATIVES · HYPERTRIGLYCERIDEMIA ·+1
PALMETTO PHARMA

FENOFIBRATE

FIBRIC ACID DERIVATIVES · HYPERTRIGLYCERIDEMIA ·+1
WESTMINSTER PHA

FENOFIBRATE

FIBRIC ACID DERIVATIVES · HYPERTRIGLYCERIDEMIA ·+1
LIFESTAR PHARMA

GEMFIBROZIL

FIBRIC ACID DERIVATIVES · HYPERTRIGLYCERIDEMIA ·+1
DENTON PHARMA I

GEMFIBROZIL

FIBRIC ACID DERIVATIVES · HYPERTRIGLYCERIDEMIA ·+1
APHENA PHARMA S

GEMFIBROZIL

FIBRIC ACID DERIVATIVES · HYPERTRIGLYCERIDEMIA ·+1
XLCARE PHARMACE
Filter & compare in the drug finder → Opens the drug finder with Fibric Acid Derivatives preselected. Add indication or manufacturer filters there.

About Fibric Acid Derivatives.

Fibric acid derivatives, commonly referred to as fibrates, are a class of lipid-lowering medications that include agents such as gemfibrozil and fenofibrate.

They function primarily as agonists of the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha), which alters the transcription of genes regulating lipoprotein metabolism, enhances lipoprotein lipase activity, stimulates cellular fatty acid beta-oxidation, and substantially decreases circulating plasma triglycerides while modestly increasing high-density lipoprotein cholesterol.

Clinically, these agents are primarily indicated as adjuncts to diet for the treatment of severe hypertriglyceridemia—often to reduce the risk of acute pancreatitis—and are also utilized in the management of mixed dyslipidemia and primary hypercholesterolemia.